|
02.11.2015 22:05:29
|
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015
GAITHERSBURG, Md., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its third quarter 2015 financial and operating results before the open of U.S. financial markets on Monday, November 9, 2015.
In addition, management will host a conference call to discuss the quarterly results and provide an update on corporate activities.
| Conference call details are as follows: | |
| Date: | November, 9th 2015 |
| Time: | 8:00 am US Eastern Time (ET) |
| Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
| Via web: | www.novavax.com, "Investors"/ "Events" |
| Conference call replay: | |
| Dates: | Starting at 11:00 am ET, November 9, 2015 until midnight November 16, 2015 |
| Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
| Passcode: | 70778771 |
| Via web: | www.novavax.com, "Investors"/ "Events" |
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for ground-breaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the company's website,novavax.com.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Novavax Inc.mehr Analysen
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.